Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Align Technology, Inc. stock logo
ALGN
Align Technology
$310.50
-1.0%
$313.38
$176.34
$413.20
$23.37B1.65756,560 shs1.65 million shs
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$103.81
+0.3%
$109.54
$77.56
$116.04
$25.25B0.682.27 million shs1.64 million shs
McKesson Co. stock logo
MCK
McKesson
$539.94
+0.8%
$527.50
$352.34
$543.00
$70.95B0.45686,906 shs446,710 shs
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Align Technology, Inc. stock logo
ALGN
Align Technology
-1.05%+3.04%-2.95%+17.49%-12.42%
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
+0.27%-2.07%-7.00%-1.79%+29.13%
McKesson Co. stock logo
MCK
McKesson
+0.82%+4.07%+0.72%+11.31%+50.30%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Align Technology, Inc. stock logo
ALGN
Align Technology
4.5946 of 5 stars
2.34.00.03.83.02.53.1
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
4.362 of 5 stars
1.34.03.33.61.91.73.1
McKesson Co. stock logo
MCK
McKesson
4.8522 of 5 stars
2.45.03.33.03.12.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Align Technology, Inc. stock logo
ALGN
Align Technology
2.50
Moderate Buy$341.369.94% Upside
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
2.55
Moderate Buy$103.07-0.71% Downside
McKesson Co. stock logo
MCK
McKesson
2.83
Moderate Buy$533.50-1.19% Downside

Current Analyst Ratings

Latest CAH, MCK, and ALGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2024
Align Technology, Inc. stock logo
ALGN
Align Technology
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$344.00 ➝ $360.00
4/25/2024
Align Technology, Inc. stock logo
ALGN
Align Technology
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$355.00 ➝ $375.00
4/25/2024
Align Technology, Inc. stock logo
ALGN
Align Technology
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$333.00 ➝ $370.00
4/18/2024
Align Technology, Inc. stock logo
ALGN
Align Technology
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$350.00 ➝ $400.00
4/15/2024
Align Technology, Inc. stock logo
ALGN
Align Technology
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$280.00 ➝ $320.00
4/15/2024
McKesson Co. stock logo
MCK
McKesson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$522.00 ➝ $548.00
4/10/2024
McKesson Co. stock logo
MCK
McKesson
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$510.00 ➝ $570.00
3/15/2024
Align Technology, Inc. stock logo
ALGN
Align Technology
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$340.00 ➝ $350.00
3/14/2024
Align Technology, Inc. stock logo
ALGN
Align Technology
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$335.00 ➝ $355.00
3/6/2024
McKesson Co. stock logo
MCK
McKesson
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$575.00 ➝ $620.00
2/26/2024
Align Technology, Inc. stock logo
ALGN
Align Technology
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Align Technology, Inc. stock logo
ALGN
Align Technology
$3.86B6.05$8.42 per share36.89$47.40 per share6.55
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$205.01B0.12$8.72 per share11.90($11.20) per share-9.27
McKesson Co. stock logo
MCK
McKesson
$276.71B0.26$32.70 per share16.51($10.99) per share-49.13

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Align Technology, Inc. stock logo
ALGN
Align Technology
$445.05M$5.8253.3534.695.5911.52%13.88%8.26%7/24/2024 (Estimated)
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$261M$2.5440.8713.041.000.30%-57.44%3.89%5/2/2024 (Confirmed)
McKesson Co. stock logo
MCK
McKesson
$3.56B$22.0724.4617.381.410.99%-262.63%5.96%5/7/2024 (Confirmed)

Latest CAH, MCK, and ALGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
McKesson Co. stock logo
MCK
McKesson
$6.39N/A-$6.39N/AN/AN/A  
5/2/2024N/A
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$1.96N/A-$1.96N/AN/AN/A  
2/7/2024Q3 2024
McKesson Co. stock logo
MCK
McKesson
$7.05$7.74+$0.69$11.06$77.93 billion$80.90 billion    
2/1/2024Q2 2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$1.56$1.82+$0.26$2.21$57.02 billion$57.45 billion    
1/31/2024Q4 2023
Align Technology, Inc. stock logo
ALGN
Align Technology
$1.78$1.91+$0.13$2.18$928.57 million$956.73 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Align Technology, Inc. stock logo
ALGN
Align Technology
N/AN/AN/AN/AN/A
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.001.93%+1.00%78.74%27 Years
McKesson Co. stock logo
MCK
McKesson
$2.480.46%+11.80%11.24%16 Years

Latest CAH, MCK, and ALGN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/24/2024
McKesson Co. stock logo
MCK
McKesson
quarterly$0.620.47%6/3/20246/3/20247/1/2024
2/6/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
quarterly$0.50061.92%3/28/20244/1/20244/15/2024
2/1/2024
McKesson Co. stock logo
MCK
McKesson
quarterly$0.620.5%2/29/20243/1/20244/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Align Technology, Inc. stock logo
ALGN
Align Technology
N/A
1.18
1.04
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
N/A
0.98
0.50
McKesson Co. stock logo
MCK
McKesson
N/A
0.92
0.50

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
88.43%
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
87.17%
McKesson Co. stock logo
MCK
McKesson
85.07%

Insider Ownership

CompanyInsider Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
0.64%
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
0.15%
McKesson Co. stock logo
MCK
McKesson
0.21%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Align Technology, Inc. stock logo
ALGN
Align Technology
21,61075.25 million74.77 millionOptionable
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
48,000243.23 million242.87 millionOptionable
McKesson Co. stock logo
MCK
McKesson
51,000131.41 million131.13 millionOptionable

CAH, MCK, and ALGN Headlines

SourceHeadline
McKesson (NYSE:MCK) Upgraded by StockNews.com to Strong-BuyMcKesson (NYSE:MCK) Upgraded by StockNews.com to Strong-Buy
marketbeat.com - April 25 at 11:14 PM
McKesson Co. (NYSE:MCK) Shares Purchased by Alaska Permanent Fund CorpMcKesson Co. (NYSE:MCK) Shares Purchased by Alaska Permanent Fund Corp
marketbeat.com - April 25 at 10:31 AM
Buy Rating Reaffirmed for McKesson Amid Strong Growth Prospects and OptumRx Contract WinBuy Rating Reaffirmed for McKesson Amid Strong Growth Prospects and OptumRx Contract Win
markets.businessinsider.com - April 25 at 9:50 AM
Ontada Names Jade Cusick Chief Commercial OfficerOntada Names Jade Cusick Chief Commercial Officer
finance.yahoo.com - April 25 at 9:50 AM
The Supreme Court Eliminates the Right to Mass Protest in Three U.S. StatesThe Supreme Court Eliminates the Right to Mass Protest in Three U.S. States
msn.com - April 25 at 9:50 AM
Leerink Partnrs Weighs in on McKesson Co.s Q3 2025 Earnings (NYSE:MCK)Leerink Partnrs Weighs in on McKesson Co.'s Q3 2025 Earnings (NYSE:MCK)
americanbankingnews.com - April 25 at 2:36 AM
Wynn Capital LLC Invests $1.98 Million in McKesson Co. (NYSE:MCK)Wynn Capital LLC Invests $1.98 Million in McKesson Co. (NYSE:MCK)
marketbeat.com - April 24 at 6:36 PM
Outperforming Pharma Stock Ready To Run HigherOutperforming Pharma Stock Ready To Run Higher
forbes.com - April 24 at 1:47 PM
McKesson Co. to Issue Quarterly Dividend of $0.62 (NYSE:MCK)McKesson Co. to Issue Quarterly Dividend of $0.62 (NYSE:MCK)
marketbeat.com - April 24 at 10:36 AM
Barclays Reaffirms Their Buy Rating on McKesson (MCK)Barclays Reaffirms Their Buy Rating on McKesson (MCK)
markets.businessinsider.com - April 24 at 8:46 AM
McKesson Corporation Declares Quarterly DividendMcKesson Corporation Declares Quarterly Dividend
businesswire.com - April 24 at 8:00 AM
Q3 2025 EPS Estimates for McKesson Co. (NYSE:MCK) Raised by AnalystQ3 2025 EPS Estimates for McKesson Co. (NYSE:MCK) Raised by Analyst
marketbeat.com - April 24 at 6:49 AM
SCOTUS should be protecting protesters’ rights | Not to Get Political ButSCOTUS should be protecting protesters’ rights | Not to Get Political But
dailyfreepress.com - April 24 at 3:46 AM
Q2 2025 EPS Estimates for McKesson Co. Raised by Leerink Partnrs (NYSE:MCK)Q2 2025 EPS Estimates for McKesson Co. Raised by Leerink Partnrs (NYSE:MCK)
americanbankingnews.com - April 24 at 2:44 AM
VIDEO: Maryland officer hits suspect 8 times in head after being spat onVIDEO: Maryland officer hits suspect 8 times in head after being spat on
wpde.com - April 23 at 10:45 PM
BLM activist DeRay McKesson still hounded by wild lawsuitBLM activist DeRay McKesson still hounded by 'wild' lawsuit
baltimoresun.com - April 23 at 5:45 PM
McKesson Co. (NYSE:MCK) Shares Sold by New York State Common Retirement FundMcKesson Co. (NYSE:MCK) Shares Sold by New York State Common Retirement Fund
marketbeat.com - April 23 at 12:28 PM
Q2 2025 Earnings Estimate for McKesson Co. Issued By Leerink Partnrs (NYSE:MCK)Q2 2025 Earnings Estimate for McKesson Co. Issued By Leerink Partnrs (NYSE:MCK)
marketbeat.com - April 23 at 6:31 AM
Buy Rating Affirmed: McKesson’s Strategic Growth Bolstered by OptumRx Contract WinBuy Rating Affirmed: McKesson’s Strategic Growth Bolstered by OptumRx Contract Win
markets.businessinsider.com - April 23 at 3:10 AM
The Supreme Court Declined a Protestors Rights Case. Heres What You Need to Know.The Supreme Court Declined a Protestors' Rights Case. Here's What You Need to Know.
aclu.org - April 22 at 10:10 PM
Wedge Capital Management L L P NC Sells 9,263 Shares of McKesson Co. (NYSE:MCK)Wedge Capital Management L L P NC Sells 9,263 Shares of McKesson Co. (NYSE:MCK)
marketbeat.com - April 22 at 6:08 PM
Car­di­nal Health los­es Op­tum­Rx con­tract to McKessonCar­di­nal Health los­es Op­tum­Rx con­tract to McKesson
endpts.com - April 22 at 5:07 PM
The Top 3 Healthcare Stocks to Buy in April 2024The Top 3 Healthcare Stocks to Buy in April 2024
investorplace.com - April 22 at 4:02 PM
Drug distributor Cardinal Health to lose OptumRx contractsDrug distributor Cardinal Health to lose OptumRx contracts
msn.com - April 22 at 12:05 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Align Technology logo

Align Technology

NASDAQ:ALGN
Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.
Cardinal Health logo

Cardinal Health

NYSE:CAH
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
McKesson logo

McKesson

NYSE:MCK
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.